About this document
Study Protocol Open Access: BMC Psychiatry by Carlitos Strapazoli is a document available to read on EtoBox.
This study protocol outlines a series of N-of-1 trials to evaluate the effectiveness of cannabidiol (CBD) for severe behavioral manifestations in patients with rare genetic neurodevelopmental disorders (RGNDs) such as Tuberous Sclerosis Complex, mucopolysaccharidosis type III, and Fragile X syndrome. The trials will be placebo-controlled and double-blind, involving 30 patients aged 6 years and older, with a focus on measuring irritability and other behavioral outcomes. The innovative design aims to address
- Author
- Carlitos Strapazoli
- Language
- EN